What are special considerations when starting someone on Wellbutrin (bupropion)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Special Considerations When Starting Wellbutrin (Bupropion)

When starting a patient on Wellbutrin (bupropion), it is essential to avoid use in patients with seizure disorders, screen for agitation, and start with a low dose of 37.5 mg every morning, then increase by 37.5 mg every 3 days to a target of 150 mg twice daily, with the second dose given before 3 PM to minimize insomnia risk. 1

Patient Selection and Contraindications

  • Absolute contraindications include:

    • Seizure disorder or history of seizures 2
    • Current or prior diagnosis of bulimia or anorexia nervosa 2
    • Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs 2
    • Concurrent use of MAOIs or within 14 days of discontinuing MAOIs 2
    • Known hypersensitivity to bupropion 2
  • Use with caution in patients with:

    • Agitation (should not be used in agitated patients) 1
    • History of head trauma or prior seizures
    • Liver or kidney dysfunction 3
    • Advanced age 3
    • Cardiovascular disease 3

Dosing Strategy

  1. Initial dosing: Start with 37.5 mg every morning 1
  2. Titration: Increase by 37.5 mg every 3 days 1
  3. Target dose: 150 mg twice daily 1
  4. Timing: To minimize insomnia risk, administer the second dose before 3 PM 1
  5. Duration of trial: A full therapeutic trial requires at least 4-8 weeks 1

Monitoring for Adverse Effects

  • Common side effects to monitor for:

    • Insomnia and activation (most common) 4
    • Dry mouth 4
    • Headache 4
    • Nausea 4
    • Constipation 2
    • Dizziness 2
  • Serious adverse effects requiring immediate attention:

    • Seizures (discontinue immediately and do not restart) 2
    • Neuropsychiatric symptoms (anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness) 2
    • Suicidal ideation, especially in young adults (18-24 years) 2
    • Severe allergic reactions 2
    • Angle-closure glaucoma (can cause mild pupillary dilation) 2

Drug Interactions

  • Important interactions to consider:
    • Do not combine with other bupropion-containing products (Zyban, Wellbutrin SR, Aplenzin) 2
    • Avoid alcohol (can increase seizure risk and decrease alcohol tolerance) 2
    • Use caution with drugs metabolized by CYP2D6 4
    • Contraindicated with MAOIs 2
    • Caution with opioids (may reduce efficacy) 3

Special Populations

  • Elderly patients: May be given full adult doses of bupropion, but monitor closely 5
  • Patients with depression and psychosis: Require concomitant antipsychotic medication 1
  • Patients with suicidal ideation: Bupropion may be relatively safer in overdose compared to TCAs, but still requires close monitoring 5

Discontinuation

  • After 9 months, consider dosage reduction to reassess the need for medication 1
  • Discontinue gradually over 10-14 days to limit withdrawal symptoms 1
  • Never discontinue abruptly, especially in elderly patients 3

Clinical Pearls

  • Bupropion is activating and may provide rapid improvement in energy levels 1
  • It has a lower incidence of sexual dysfunction compared to SSRIs 4, 6
  • It may cause less weight gain than other antidepressants 7
  • In rare cases, bupropion can cause acute dystonia, particularly with dose increases 8
  • Patients should refrain from driving or operating complex machinery until they are reasonably certain bupropion does not adversely affect their performance 2

By following these guidelines, clinicians can optimize the safety and efficacy of bupropion treatment while minimizing adverse effects and complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Psychiatric and Medical Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bupropion: pharmacology and therapeutic applications.

Expert review of neurotherapeutics, 2006

Research

Review of bupropion.

Clinical pharmacy, 1983

Research

15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.

Primary care companion to the Journal of clinical psychiatry, 2005

Research

Bupropion-induced acute dystonia.

The Annals of pharmacotherapy, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.